ERBB2 and breast cancer: A single-institute study of 119 breast cancer patients observed a stronger association between radiological complete response (CR) for cancers with HR−/HER2+ status than those with HR+/HER2+ status, where radiological CR was assessed using ultrasound or MRI [22].